Evidence map›Paper›PMID 33532682›Full record

ArticleAnnals of gastroenterological surgery2021

Comparison of the continuation and discontinuation of perioperative antiplatelet therapy in laparoscopic surgery for colorectal cancer: A retrospective, multicenter, observational study (YCOG 1603).

Hiroki Ohya, Jun Watanabe, Yusuke Suwa, Kazuya Nakagawa, Hirokazu Suwa, Mayumi Ozawa, Atsushi Ishibe, Chikara Kunisaki, Itaru Endo

Abstract read
In one paragraph

Article in Annals of gastroenterological surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Under any circumstances, perform the best treatment for cancer.Annals of gastroenterological surgery · 2021
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hiroki OhyaDepartment of Surgery Gastroenterological Center Yokohama City University Medical Center Yokohama Japan.ORCID https://orcid.org/0000-0002-5215-3960
Jun WatanabeDepartment of Surgery Gastroenterological Center Yokohama City University Medical Center Yokohama Japan.ORCID https://orcid.org/0000-0002-7187-3664
Yusuke SuwaDepartment of Surgery Gastroenterological Center Yokohama City University Medical Center Yokohama Japan.
Kazuya NakagawaDepartment of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.ORCID https://orcid.org/0000-0002-7504-7255
Hirokazu SuwaDepartment of Surgery Yokosuka Kyosai Hospital Yokosuka Japan.
Mayumi OzawaDepartment of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.
Atsushi IshibeDepartment of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.ORCID https://orcid.org/0000-0002-3251-3658
Chikara KunisakiDepartment of Surgery Gastroenterological Center Yokohama City University Medical Center Yokohama Japan.
Itaru EndoDepartment of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.ORCID https://orcid.org/0000-0001-5520-8114

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe present study aimed to examine the effect of continuing antiplatelet therapy in the perioperative period for patients undergoing laparoscopic resection for colorectal cancer who had received preoperative antiplatelet therapy.

methodsThis retrospective, multicenter, observational study included patients who underwent laparoscopic surgery for colorectal cancer between January 2011 and May 2020. The study population was limited to patients who used antiplatelet therapy preoperatively.

resultsA total of 214 colorectal cancer patients who received antiplatelet therapy preoperatively were included in the present study. Eighty-nine patients underwent surgery under the continuation of antiplatelet therapy, and 125 patients underwent surgery under the discontinuation of antiplatelet therapy before surgery. There were no significant differences between the two groups with regard to intraoperative blood loss (

conclusionsThe present study revealed that there were no significant differences in the surgical outcomes and postoperative complications between colorectal cancer patients who underwent laparoscopic resection with the continuation of antiplatelet therapy in the perioperative period and those in whom antiplatelet therapy was discontinued during the perioperative period. From the viewpoint of cardiovascular and cerebrovascular risk, it may be better for patients undergoing laparoscopic surgery for colorectal cancer to continue antiplatelet therapy. This study was registered with the Japanese Clinical Trials Registry as UMIN000038707 (http://www.umin.ac.jp/ctr/index.htm).

Indexed as

antiplatelet therapycardiovascular eventscolorectal cancerhemorrhagic complicationlaparoscopic surgery

Identifiers

PMID33532682
PMCPMC7832956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.